Neoadjuvant chemoradiotherapy to convert borderline-resectable, locally-advanced esophageal carcinoma to resectable disease.

被引：1
|
作者：
Horne, Zachary D.
Sun, Weijing
Gibson, Michael K.
Pennathur, Arjun
Luketich, James D.
Greenberger, Joel S.
机构：
[1] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Hosp Cleveland, Case Comprehens Canc Ctr, Med Ctr, Cleveland, OH 44106 USA
[4] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[5] Univ Pittsburgh, Div Thorac Surg, Pittsburgh, PA USA
[6] Univ Pittsburgh, Med Ctr Canc Pavil, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e15500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15500
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis
    Fossum, Croix C.
    Alabbad, Jasim Y.
    Romak, Lindsay B.
    Hallemeier, Christopher L.
    Haddock, Michael G.
    Huebner, Marianne
    Dozois, Eric J.
    Larson, David W.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (04) : 650 - 658
  • [42] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [43] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [44] Neo-adjuvant FOLFIRINOX in borderline-resectable/locally advanced pancreatic adenocarcinoma: An updated analysis
    Temraz, S.
    Hammoud, M. Salim
    Zorkot, M.
    Albonji, W.
    Dbouk, H.
    Farhat, F.
    Charafeddine, M.
    Mukherji, D.
    Shamseddine, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
    Chawla, Akhil
    Molina, George
    Pak, Linda M.
    Rosenthal, Michael
    Mancias, Joseph D.
    Clancy, Thomas E.
    Wolpin, Brian M.
    Wang, Jiping
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (04) : 1191 - 1200
  • [46] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [47] Neoadjuvant therapy response and survival in borderline resectable and locally-advanced pancreatic ductal adenocarcinoma; the largest UK case series
    Khaled, Yazan
    Suresh, Nikhil
    Tetley, Heather
    Young, Alistair
    Pine, James
    Pathak, Samir
    Smith, Andrew
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [48] Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
    Akhil Chawla
    George Molina
    Linda M. Pak
    Michael Rosenthal
    Joseph D. Mancias
    Thomas E. Clancy
    Brian M. Wolpin
    Jiping Wang
    Annals of Surgical Oncology, 2020, 27 : 1191 - 1200
  • [49] Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma
    Reza, Joseph Arturo
    Monreal, Alberto
    Meyer, Patrick Hunter
    Patel, Swati
    Zakari, Ahmed
    de la Fuente, Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [50] Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer
    Han, Sunjong
    Choi, Seong H.
    Choi, Dong W.
    Heo, Jin S.
    Han, In W.
    Park, Dae-Joon
    Ryu, Youngju
    MINERVA CHIRURGICA, 2020, 75 (01) : 15 - 24
12345